Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is the third most fatal cancer, with a 5-year survival rate of 18%. Standard frontline-therapy is multikinase inhibitors (MKIs), but accessibility is still limited, particularly in developing countries. This network meta-analysis (NMA) aimed to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Oranratnachai, Songporn, Rattanasiri, Sasivimol, Pooprasert, Anantaporn, Tansawet, Amarit, Reungwetwattana, Thanyanan, Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044881/
https://www.ncbi.nlm.nih.gov/pubmed/33869060
http://dx.doi.org/10.3389/fonc.2021.654020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044881/
https://www.ncbi.nlm.nih.gov/pubmed/33869060
http://dx.doi.org/10.3389/fonc.2021.654020

Ejemplares similares